All In MedTech

FDA Clearance Tracker · K222463

EchoGo Heart Failure

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 19, 2026Latest source record: Nov 23, 2022 (this decision)Source: openFDAMethods & limitations

510(k)First of its product codeBreakthrough

Decided

Nov 23, 2022

Substantially Equivalent

Time to decision

100 days

Received Aug 15, 2022. Calendar days, including time FDA spent waiting on the applicant.

Pathway

510(k)

Traditional

Device class

Class II

The decision

FDA number
K222463
Device name
EchoGo Heart Failure
Applicant location
Oxford, GB
Received
Aug 15, 2022
Decided
Nov 23, 2022
Decision
Substantially Equivalent
Submission type
Traditional

Device type

Device class
Class II
Regulation
21 CFR 870.2200
Specialty
Cardiology

Every decision under product code QUO

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • This is the earliest decision in FDA's data under product code QUO (Adjunctive Heart Failure Status Indicator).
  • It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).

Source documents

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for Ultromics Limited

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.